BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 22952576)

  • 21. Prospective Series of Nine Long Noncoding RNAs Associated with Survival of Patients with Glioblastoma.
    Lei B; Yu L; Jung TA; Deng Y; Xiang W; Liu Y; Qi S
    J Neurol Surg A Cent Eur Neurosurg; 2018 Nov; 79(6):471-478. PubMed ID: 29959764
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aminoacyl-tRNA synthetase-interacting multifunctional proteins (AIMPs): a triad for cellular homeostasis.
    Park SG; Choi EC; Kim S
    IUBMB Life; 2010 Apr; 62(4):296-302. PubMed ID: 20306515
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bioinformatics analysis of potential core genes for glioblastoma.
    Zhang Y; Yang X; Zhu XL; Hao JQ; Bai H; Xiao YC; Wang ZZ; Hao CY; Duan HB
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32667033
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aminoacyl-tRNA synthetases and tumorigenesis: more than housekeeping.
    Kim S; You S; Hwang D
    Nat Rev Cancer; 2011 Sep; 11(10):708-18. PubMed ID: 21941282
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
    Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
    Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Roles of Aminoacyl-tRNA Synthetases in Cancer.
    Zhou Z; Sun B; Nie A; Yu D; Bian M
    Front Cell Dev Biol; 2020; 8():599765. PubMed ID: 33330488
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of hub genes and regulatory factors of glioblastoma multiforme subgroups by RNA-seq data analysis.
    Li Y; Min W; Li M; Han G; Dai D; Zhang L; Chen X; Wang X; Zhang Y; Yue Z; Liu J
    Int J Mol Med; 2016 Oct; 38(4):1170-8. PubMed ID: 27572852
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integrative analysis of DNA methylation and gene expression to identify key epigenetic genes in glioblastoma.
    Jia D; Lin W; Tang H; Cheng Y; Xu K; He Y; Geng W; Dai Q
    Aging (Albany NY); 2019 Aug; 11(15):5579-5592. PubMed ID: 31395792
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A robust two-gene signature for glioblastoma survival prediction.
    Pan Y; Zhang JH; Zhao L; Guo JC; Wang S; Zhao Y; Tao S; Wang H; Zhu YB
    J Cell Biochem; 2020 Jul; 121(7):3593-3605. PubMed ID: 31960992
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Network signatures of survival in glioblastoma multiforme.
    Patel VN; Gokulrangan G; Chowdhury SA; Chen Y; Sloan AE; Koyutürk M; Barnholtz-Sloan J; Chance MR
    PLoS Comput Biol; 2013; 9(9):e1003237. PubMed ID: 24068912
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Meta-analysis of glioblastoma multiforme versus anaplastic astrocytoma identifies robust gene markers.
    Dreyfuss JM; Johnson MD; Park PJ
    Mol Cancer; 2009 Sep; 8():71. PubMed ID: 19732454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High expression of RFX4 is associated with tumor progression and poor prognosis in patients with glioblastoma.
    Jeong HY; Kim HJ; Kim CE; Lee S; Choi MC; Kim SH
    Int J Neurosci; 2021 Jan; 131(1):7-14. PubMed ID: 32075484
    [No Abstract]   [Full Text] [Related]  

  • 33. Prognostic risk model construction and molecular marker identification in glioblastoma multiforme based on mRNA/microRNA/long non-coding RNA analysis using random survival forest method.
    Wang H; Liu D; Yang J
    Neoplasma; 2019 May; 66(3):459-469. PubMed ID: 30784292
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PARP-1 protein expression in glioblastoma multiforme.
    Galia A; Calogero AE; Condorelli R; Fraggetta F; La Corte A; Ridolfo F; Bosco P; Castiglione R; Salemi M
    Eur J Histochem; 2012 Feb; 56(1):e9. PubMed ID: 22472897
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genome-wide oligonucleotide microarray analysis of gene-expression profiles of Taiwanese patients with anaplastic astrocytoma and glioblastoma multiforme.
    Chang CL
    J Biomol Screen; 2008 Oct; 13(9):912-21. PubMed ID: 18812569
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glioblastoma-specific protein interaction network identifies PP1A and CSK21 as connecting molecules between cell cycle-associated genes.
    Ladha J; Donakonda S; Agrawal S; Thota B; Srividya MR; Sridevi S; Arivazhagan A; Thennarasu K; Balasubramaniam A; Chandramouli BA; Hegde AS; Kondaiah P; Somasundaram K; Santosh V; Rao SM
    Cancer Res; 2010 Aug; 70(16):6437-47. PubMed ID: 20663907
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gene expression profiling reveals Ki-67 associated proliferation signature in human glioblastoma.
    Jin Q; Zhang W; Qiu XG; Yan W; You G; Liu YW; Jiang T; Wang L
    Chin Med J (Engl); 2011 Sep; 124(17):2584-8. PubMed ID: 22040407
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PI3 kinase pathway regulated miRNome in glioblastoma: identification of miR-326 as a tumour suppressor miRNA.
    Nawaz Z; Patil V; Paul Y; Hegde AS; Arivazhagan A; Santosh V; Somasundaram K
    Mol Cancer; 2016 Nov; 15(1):74. PubMed ID: 27871300
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estimating survival time of patients with glioblastoma multiforme and characterization of the identified microRNA signatures.
    Yerukala Sathipati S; Huang HL; Ho SY
    BMC Genomics; 2016 Dec; 17(Suppl 13):1022. PubMed ID: 28155650
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A 63 signature genes prediction system is effective for glioblastoma prognosis.
    Zhang Y; Xu J; Zhu X
    Int J Mol Med; 2018 Apr; 41(4):2070-2078. PubMed ID: 29393370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.